Particularly in ovarian cancers (OCs), the most lethal gynecologic malignancies in the developed world and the fifth leading cause of cancer-associated mortality among women in the United States [13], SWI/SNF alterations vary in different histologic subtypes. This evidence concerns the gene SMARCA1 and ovarian carcinoma.